Summary
Thank you for your interest in this position. The NEI, Division of Epidemiology and Clinical Applications will accept applications on December 31, 2024 through January 31, 2025 at the email address below.
Interested candidates, please submit your Curriculum Vitae/Bibliography and letter of intent to Mr. William R. O'Donnell, MBA , MS at: wrod@nei.nih.gov.
Requirements
Conditions of Employment
The individual selected for this position will be an ophthalmologist who has had fellowship training in medical retina or vitreoretinal surgery. This individual may have had clinical trials training or has special interest in conducting clinical research in the field of retinal diseases.
Qualifications
The successful individual will possess an MD degree and have completed an accredited residency in ophthalmology and is ABO boarded or board eligible with an interest in retinal and macular diseases. Subspecialty training in retina is required.
Benefits
A career with the U.S. government provides employees with a comprehensive benefits package. As a federal employee, you and your family will have access to a range of benefits that are designed to make your federal career very rewarding. Opens in a new windowLearn more about federal benefits.
Review our benefits
Eligibility for benefits depends on the type of position you hold and whether your position is full-time, part-time or intermittent. Contact the hiring agency for more information on the specific benefits offered.
How to Apply
Thank you for your interest in this position. Interested candidates, please submit your Curriculum Vitae/Bibliography and letter of intent to Mr. William R. O'Donnell, MBA , MS at: wrod@nei.nih.gov.
NIH's EEO and Diversity and Inclusion Policy Statement
Visit the NIH's Office of Equity, Diversity, and Inclusion site for information on NIH's EEO program, Reasonable accommodation procedures, laws, policy statements, and the operation of the EEO complaint process.
Next steps
If interested, we encourage you to apply during the opening period 12/31/2024 through 1/31/2025.